Therapeutic targets for diabetic nephropathy identified by druggable genome mendelian randomization: the role of the gut microbiota-metabolite axis - Poll - MDSpire

Therapeutic targets for diabetic nephropathy identified by druggable genome mendelian randomization: the role of the gut microbiota-metabolite axis

  • By

  • Ling Niu

  • Rong Ma

  • Cuijuan Miao

  • Fang Liu

  • Boyi Li

  • May 8, 2026

  • 0 min

Share

Original Source(s)

Therapeutic targets for diabetic nephropathy identified by druggable genome mendelian randomization: the role of the gut microbiota-metabolite axis

  • by Ling Niu, Rong Ma, Cuijuan Miao, Fang Liu, Boyi Li

  • May 8, 2026

Related Content

Determinants of pediatric urolithiasis hospitalizations in endemic and non-endemic regions of Mexico

Obstacles and Results in Kidney Transplantation for Pediatric and Adult Patients

Is creatine kinase a valid aid in early cardiac muscle damage detection during treatment for childhood acute lymphoblastic leukemia? A case report